Jump to content

ATC code H05

From Wikipedia, the free encyclopedia

ATC code H05 Calcium homeostasis is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H05 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH05.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H05A Parathyroid hormones and analogues

[edit]

H05AA Parathyroid hormones and analogues

[edit]
H05AA01 Parathyroid gland extract
H05AA02 Teriparatide
H05AA03 Parathyroid hormone
H05AA04 Abaloparatide
H05AA05 Palopegteriparatide

H05B Anti-parathyroid agents

[edit]

H05BA Calcitonin preparations

[edit]
H05BA01 Calcitonin (salmon synthetic)
H05BA02 Calcitonin (pork natural)
H05BA03 Calcitonin (human synthetic)
H05BA04 Elcatonin

H05BX Other anti-parathyroid agents

[edit]
H05BX01 Cinacalcet
H05BX02 Paricalcitol
H05BX03 Doxercalciferol
H05BX04 Etelcalcetide
H05BX05 Calcifediol
H05BX06 Evocalcet

References

[edit]
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code H05". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QH05". WHO Collaborating Centre for Drug Statistics Methodology.